UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
38.24
-2.85 (-6.94%)
At close: Jul 31, 2026, 4:00 PM EDT
38.72
+0.48 (1.26%)
After-hours: Jul 31, 2026, 6:44 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.86 billion as of July 31, 2026. Its market cap has increased by 110.24% in one year.
Market Cap
1.86B
Enterprise Value
1.92B
1-Year Change
110.24%
Ranking
Category
Stock Price
$38.24
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.86B, an increase of 924.25%. That is a compound annual growth rate of 28.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.86B | 69.95% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 2.07B |
| Harmony Biosciences Holdings | 2.07B |
| Palvella Therapeutics | 2.05B |
| Zenas BioPharma | 2.04B |
| ADMA Biologics | 2.04B |
| Rapport Therapeutics | 2.01B |
| SELLAS Life Sciences Group | 1.98B |
| Precigen | 1.97B |